Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Deutsche Boerse AG  >  GlaxoSmithKline plc    GS7   GB0009252882

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo GlaxoSmithKline plc
Develops, manufactures and distributes vaccines and other pharmaceutical products

GlaxoSmithKline Plc operates as a science-led global healthcare company that researches and develops a broad range of innovative medicines and brands.

It operates in three primary areas of business: Pharmaceuticals, Vaccines and Consumer Healthcare.

The Pharmaceuticals business researches, develops and makes available medicines that treat a variety of serious and chronic diseases.

The Vaccines business produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza and bacterial meningitis.

The Consumer Healthcare business markets a range of consumer health products based on scientific innovation.

The company was founded on December 6, 1999 and is headquartered in Brentford, United Kingdom.
Managers
NameAgeSinceTitle
Andrew Witty512008Chief Executive Officer & Executive Director
Philip Hampton522015Non-Executive Chairman
Simon Dingemans522011Chief Financial Officer & Executive Director
Birgitte Volck MD, PhD542016Head-Research & Development
Moncef Slaoui, PhD552006Executive Director & Chairman-Global Vaccines
Roy Malcolm Anderson682007Independent Non-Executive Director
Stacey Cartwright522011Independent Non-Executive Director
Judy Carol Lewent672011Independent Non-Executive Director
Lynn Laverty Elsenhans, MBA592012Independent Non-Executive Director
Urs Rohner572015Independent Non-Executive Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 5,367,734,859 4,827,368,393 89.9% 491,505,950 9.2% 89.9%
Shareholders
NameEquities%
BlackRock Investment Management (UK) Ltd. 207,257,650 4.25%
Legal & General Investment Management Ltd. 147,931,457 3.03%
The Vanguard Group, Inc. 119,965,724 2.46%
Capital Research & Management Co. (Global Investors) 101,403,390 2.08%
Norges Bank Investment Management 89,260,000 1.83%
State Street Global Advisors Ltd. 61,985,143 1.27%
Threadneedle Asset Management Ltd. 57,598,053 1.18%
Aberdeen Asset Investments Ltd. 57,069,023 1.17%
Woodford Investment Management LLP 52,447,599 1.08%
Schroder Investment Management Ltd. 51,422,832 1.05%
Holdings
NameEquities%Valuation
Aspen Pharmacare Holdings Limited (APNJ) 28,234,3796.19%615,114,746 USD
Innoviva Inc (INVA) 32,005,26028.8%329,654,178 USD
Theravance Biopharma Inc (TBPH) 9,644,80720.1%242,374,000 USD
JCR Pharmaceuticals Co Ltd (4552) 7,986,00024.6%200,400,444 USD
GlaxoSmithKline S.A.E. 76,161,37891.2%95,716,573 USD
Crispr Therapeutics AG (CRSP) 3,220,6278.18%58,776,443 USD
Dong-A Socio Holdings Co Ltd (000640) 409,6936.77%51,916,526 USD
Oncomed Pharmaceuticals Inc (OMED) 2,607,5467.10%23,650,442 USD
GlaxoSmithKline Consumer Nigeria PLC (GLAXOSM) 444,065,54137.1%21,017,622 USD
Allergy Therapeutics plc (AGY) 10,118,0001.71%2,779,415 USD
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Advertisement
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
GLAXOSMITHKLINE PLC-5.69%91 041
JOHNSON & JOHNSON9.00%304 591
PFIZER INC.-2.01%191 942
ROCHE HOLDING LTD.-19.61%188 878
NOVARTIS AG-19.07%178 737
MERCK & CO., INC.15.85%168 544
SANOFI-4.20%103 510
BRISTOL-MYERS SQUIBB C..-17.95%93 522
GLAXOSMITHKLINE PLC6.85%91 041
BAYER AG-25.06%76 831
ELI LILLY AND CO-20.34%74 748
ALLERGAN PLC-39.30%71 149
NOVO NORDISK A/S-41.01%68 352
ASTRAZENECA PLC-11.62%64 588
ABBOTT LABORATORIES-15.23%55 801
SHIRE PLC-3.05%52 210
TAKEDA PHARMACEUTICAL ..-22.03%32 564
ASTELLAS PHARMA INC-9.55%29 477
MYLAN NV-33.44%19 258
EISAI CO., LTD-16.80%17 197
SHIONOGI & CO LTD-2.08%16 452
Sector Pharmaceuticals - NEC
GlaxoSmithKline plc : Connections
980 Great West road
TW8 9GS Brentford, Greater London
United Kingdom

Phone : +44 (0)20 8047 5000
Fax : +44 (0)20 8047 7807
Internet : http://www.gsk.com
Markets and indexes
- London Stock Exchange, SETS
- Main Market
- FTSE 100 / FTSE 350, FTSE All-Share, FTSE Eurotop 100, Low Carbon 100 Europe, Stoxx Europe 50, Stoxx Global 200, Stoxx UK 50
Stock Exchange Codes
- ISIN Code :  GB0009252882
- Bloomberg Code :  GSK:LN
- Reuters Code :  GSK.L
- Datastream Code :  GSK
© 2016 People , Fundamentals and Ownership    © 2016 Cofisem